177 related articles for article (PubMed ID: 23531109)
1. Meeting report: The future of preclinical mouse models in melanoma treatment is now.
Merlino G; Flaherty K; Acquavella N; Day CP; Aplin A; Holmen S; Topalian S; Van Dyke T; Herlyn M
Pigment Cell Melanoma Res; 2013 Jul; 26(4):E8-E14. PubMed ID: 23531109
[No Abstract] [Full Text] [Related]
2. Melanoma and other skin neoplasms.
Curr Opin Oncol; 1990 Apr; 2(2):443-54. PubMed ID: 2095255
[No Abstract] [Full Text] [Related]
3. Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California.
Lo RS; Ribas A; Long GV; Ballotti R; Berger M; Willy H; Gibney GT; Bosenberg M; Bernstein E; Villanueva J; Smalley KS
Pigment Cell Melanoma Res; 2013 Jul; 26(4):E1-7. PubMed ID: 23551976
[No Abstract] [Full Text] [Related]
4. Cutaneous melanoma--past, present, and future.
Schaffer JV; Rigel DS; Kopf AW; Bolognia JL
J Am Acad Dermatol; 2004 Jul; 51(1 Suppl):S65-9. PubMed ID: 15243517
[No Abstract] [Full Text] [Related]
5. [Melanoma update].
Longvert C; Saiag P
Rev Med Interne; 2019 Mar; 40(3):178-183. PubMed ID: 30527396
[TBL] [Abstract][Full Text] [Related]
6. Melanoma 2007: current state and preview of the future.
Borden EC
Semin Oncol; 2007 Dec; 34(6):449-51. PubMed ID: 18083367
[No Abstract] [Full Text] [Related]
7. Anti-Melanoma Capability of Contactless Cold Atmospheric Plasma Treatment.
Yan D; Wang Q; Yao X; Malyavko A; Keidar M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769162
[TBL] [Abstract][Full Text] [Related]
8. Active surrender.
Collisson EA
Pigment Cell Melanoma Res; 2012 May; 25(3):292-3. PubMed ID: 22629566
[No Abstract] [Full Text] [Related]
9. Therapeutic trends in cutaneous melanoma.
Hall PN; Javaid M; de Takats PG
Hosp Med; 1999 Jan; 60(1):39-43. PubMed ID: 10197097
[TBL] [Abstract][Full Text] [Related]
10. News from the melanoma sessions of the European Cancer Congress 2017.
Rutkowski P; Kozak K
BMC Med; 2017 Mar; 15(1):57. PubMed ID: 28302128
[TBL] [Abstract][Full Text] [Related]
11. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
[TBL] [Abstract][Full Text] [Related]
12. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
[TBL] [Abstract][Full Text] [Related]
13. Relationship between melanogenicity and malignancy in malignant melanoma cells.
Kim HI; Youn JK; Park YK
Yonsei Med J; 1988; 29(4):357-66. PubMed ID: 3245242
[No Abstract] [Full Text] [Related]
14. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic melanoma: a brief review and the efficacy of immunotherapy.
Ochoa CE; Joseph RW
Expert Rev Anticancer Ther; 2019 Mar; 19(3):205-207. PubMed ID: 30686076
[No Abstract] [Full Text] [Related]
16. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract][Full Text] [Related]
17. A Huge Melanoma.
Watad A; Odeh Q; Lahat NB; Amital H
Isr Med Assoc J; 2015 Dec; 17(12):787-8. PubMed ID: 26897986
[No Abstract] [Full Text] [Related]
18. The conquest of melanoma by immunotherapy.
Lejeune FJ
Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
[No Abstract] [Full Text] [Related]
19. Immunotherapy for advanced melanoma.
Fang L; Lonsdorf AS; Hwang ST
J Invest Dermatol; 2008 Nov; 128(11):2596-2605. PubMed ID: 18927541
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for melanoma.
Bystryn JC
Dermatol Clin; 2002 Oct; 20(4):717-25. PubMed ID: 12380059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
